Are Men Beating Women At The Olympics? - The Truth (comprehensive dissection)

More Plates More Dates
12 Aug 202459:17

Summary

TLDRThe video script delves into the complexities of gender eligibility in sports, particularly focusing on the cases of Imane Khelif and Lin Yu Ting, who were disqualified from women's boxing for failing gender verification tests. It explores the nuances of biological sex, the role of androgens, and the debate surrounding fairness in competitive sports. The script also examines the history of sex verification in the Olympics and the varying rules across different sports, highlighting the need for clear and fair criteria to ensure equitable competition.

Takeaways

  • 🥊 The script discusses the controversy surrounding Imane Khelif and Lin Yu Ting's gold medal wins in Olympic women's boxing due to concerns about potential performance-enhancing advantages from being biologically male.
  • 🏅 Both athletes had previously been disqualified for failing a gender verification test, which indicated they might be biological men, but the criteria for eligibility in women's sports is complex and not uniformly applied across sports.
  • 🧬 The International Boxing Association (IBA) confirmed that the athletes had 'male karyotype,' suggesting the presence of XY chromosomes typically found in males, which was a key factor in their disqualification.
  • 🔬 The debate involves understanding the role of testosterone levels, the SRY gene, and other genetic factors that may contribute to physical attributes and athletic performance.
  • 🏆 The IOC (International Olympic Committee) has different criteria for gender eligibility compared to the IBA, leading to a conflict in how to classify athletes like Khelif and Yu Ting.
  • 💉 The use of testosterone level cut-offs as a criterion for eligibility in women's sports has been implemented in some sports, but not consistently across all Olympic events.
  • 🤔 The script raises questions about fairness in women's sports, considering the potential for individuals with male biological traits to have an unfair advantage over those with typical female biology.
  • 🏋️‍♀️ The discussion includes the impact of conditions like Androgen Insensitivity Syndrome and 5 Alpha Reductase Deficiency on physical development and athletic performance.
  • 🧐 The script emphasizes the need for clear and consistent criteria for gender eligibility in sports, as well as the importance of privacy and sensitivity in handling such cases.
  • 📚 It also highlights the complexity of biological sex determination and the limitations of current testing methods in ensuring a level playing field in sports competitions.

Q & A

  • What is the controversy surrounding Imane Khelif and Lin Yuting's participation in women's boxing at the Olympics?

    -The controversy revolves around the fact that both athletes were previously disqualified for failing a gender verification test, which suggested they might be biologically male. This has led to debates about potential performance-enhancing advantages and whether biological males should compete against women in sports.

  • What is a gender eligibility test, and why is it conducted?

    -A gender eligibility test is a medical examination conducted to determine an athlete's eligibility to compete in a specific gender category, typically women's sports. It is conducted to ensure fair competition by verifying that athletes meet the necessary biological criteria to compete in their declared gender category.

  • What is the International Boxing Association's (IBA) stance on Imane Khelif and Lin Yuting's disqualification?

    -The IBA disqualified both athletes based on the results of a gender eligibility test conducted during the 2023 World Championships, asserting that they did not meet the required criteria and had competitive advantages over other female competitors.

  • What does it mean to have an 'abnormal' chromosomal analysis in the context of gender eligibility testing?

    -An 'abnormal' chromosomal analysis in gender eligibility testing means that the individual's complete set of chromosomes does not align with the typical pattern seen in males (XY) or females (XX). In the case of Imane Khelif and Lin Yuting, it was revealed they had a male karyotype, indicating a biological male status.

  • How does the IOC's stance on eligibility for women's sports differ from the IBA's in the context of the discussed athletes?

    -The IOC insists that the fighters were born and raised as women, and therefore should be allowed to compete, despite the IBA's assertion that their test results suggest they are biologically male and ineligible for women's boxing.

  • What is the significance of the SRY gene in determining an individual's sex for sports eligibility?

    -The SRY gene, found on the Y chromosome, acts as a signal for male development. Its presence typically indicates a male biological status. In the past, the IOC used the detection of the SRY gene as part of sex verification testing for female athletes, but this practice has since been discontinued.

  • What is the role of testosterone in determining athletic performance and its relevance to gender eligibility in sports?

    -Testosterone is an androgen hormone that contributes to the development of male characteristics, including muscle mass and bone density, which can influence athletic performance. In some sports, testosterone levels are used as part of the criteria to assess eligibility for female categories, with certain levels requiring suppression for athletes to compete.

  • What is the history of sex verification in the Olympics, and how has it evolved over time?

    -Sex verification in the Olympics began with chromosome testing and the detection of the SRY gene. However, due to ethical concerns and the complexity of biological sex determination, this practice was discontinued by the 2000 Summer Olympics. Instead, hormone level cutoffs and specific criteria for conditions like DSD have been implemented to assess eligibility.

  • What are the implications of the Caster Semenya case for the broader discussion on gender eligibility in sports?

    -The Caster Semenya case highlights the complexities and controversies surrounding gender eligibility in sports. It brought attention to the need for a nuanced approach to determining eligibility, considering factors beyond the presence of the SRY gene and including hormone levels and their impact on performance.

  • What is the current guidance from the IOC on transgender athletes in women's sports, and how has it been received by various sports federations?

    -The IOC's 2021 guidance placed the responsibility on individual federations to determine eligibility criteria for transgender athletes in their respective sports. This has led to different approaches across sports, with some banning trans women entirely, while others have implemented testosterone level requirements for eligibility.

  • How do differences in lung volume, heart size, and other physiological factors contribute to athletic performance and gender differences in sports?

    -Physiological differences between males and females, such as lung volume, heart size, and blood volume, can impact athletic performance. Males typically have larger lung volumes and hearts, which can contribute to higher oxygen carrying capacity and cardiac output, providing a potential advantage in endurance and strength-based sports.

Outlines

00:00

🥊 Controversy in Women's Boxing: Eligibility and Advantage

The paragraph delves into the controversy surrounding Imane Khelif and Lin Yu Ting's gold medal wins in Olympic women's boxing. It discusses the speculation and public reactions to the possibility of biological men competing against women, potentially creating an unfair advantage. The script mentions that both athletes had previously failed a gender verification test, leading to their disqualification. The narrative also touches on the internet's reaction to an incident where an opponent quit mid-match due to the force of the hits, which she claimed was unprecedented. The paragraph concludes with a mention of the athletes' physical appearances, suggesting a more masculine look compared to the average female, and the complexity of the situation due to missing information.

05:01

🏅 Gender Verification Tests and the IOC's Stance

This paragraph focuses on the gender eligibility tests conducted by the International Boxing Association (IBA) and the resulting disqualification of the athletes in question. It discusses the criteria for these tests, the chromosomal analysis that revealed a male karyotype, and the subsequent interpretation that led to the athletes being deemed ineligible. The IBA's official statement is highlighted, asserting that the athletes did not meet the necessary criteria and had a competitive advantage. The paragraph also touches on the IOC's position, which differs from the IBA's, and the evolving rules regarding transgender athletes and those with differences in sex development (DSD). The IOC's guidance from 2021 is summarized, emphasizing the responsibility placed on individual federations to determine eligibility criteria and the varying approaches across different sports.

10:02

🌐 The Complexity of Eligibility Criteria and Testing

The paragraph discusses the technical differences in competition rules between the IBA and the IOC, the lack of chromosomal analysis and testosterone tests in the Olympics, and the IOC's insistence that fighters are born and raised as women. It also covers the IOC's position on the eligibility of transgender athletes and those with DSD, referencing high-profile cases such as Laurel Hubbard and Caster Semenya. The paragraph explains the new rules from World Athletics that require certain athletes to suppress their testosterone levels to compete in specific women's events, and the controversy surrounding these regulations.

15:02

🧬 History of Sex Verification in Sports

This paragraph explores the history of sex verification in the Olympics, starting with the implementation of the SRY gene test in 1992 by the IOC. It explains how athletes with this gene were initially barred from competing as females but were later allowed to compete after further investigation. The paragraph also discusses the shift from genetic testing to hormone level cutoffs and the eventual discontinuation of sex verification by the 2000 Summer Olympics. It highlights the complexity of sex determination, the role of the SRY gene, and the ethical and practical challenges of implementing sex verification in sports.

20:04

💪 The Impact of Androgen Levels on Athletic Performance

The paragraph examines the role of androgens in athletic performance, focusing on the case of Caster Semenya and the controversy surrounding her participation in women's sports. It delves into the biological aspects of androgens, their impact on muscle growth, and the debate over the fairness of including athletes with higher androgen levels in women's categories. The discussion includes the effects of 5-alpha reductase deficiency and how it can lead to individuals with male levels of testosterone who may not fully masculinize but still retain athletic advantages.

25:06

🤺 The Challenge of Defining Fairness in Sports

This paragraph discusses the challenges of defining fairness in sports, especially when it comes to athletes with unique genetic predispositions or conditions like 5-alpha reductase deficiency. It explores the spectrum of androgen sensitivity and how it can affect an athlete's physical development and performance capabilities. The paragraph emphasizes the importance of understanding the nuances of these conditions and their potential impact on competitive fairness, suggesting that a one-size-fits-all approach to eligibility may not be appropriate.

30:08

🧬 Androgen Receptor Insensitivity and Its Athletic Implications

The paragraph delves into the complexities of androgen receptor insensitivity, explaining how it can manifest in various degrees, from mild to complete, and its implications for athletic performance. It discusses the potential advantages or disadvantages that individuals with androgen insensitivity syndromes might have in sports, highlighting the importance of considering both hormone levels and their functional impact on the body when assessing eligibility for competition.

35:10

🏃‍♂️ The Spectrum of Androgen Sensitivity and Athletic Advantage

This paragraph explores the spectrum of androgen sensitivity and its potential impact on athletic performance. It discusses the anatomical and physiological differences between individuals with varying levels of androgen sensitivity, including bone density, muscle mass, lung capacity, and heart size. The paragraph also touches on the non-genomic effects of androgens, which can influence performance independently of the androgen receptor.

40:13

🤝 The Future of Gender Segregation in Sports

The final paragraph contemplates the future of gender segregation in sports, given the complexities of biological sex and the potential for unique genetic predispositions to influence performance. It questions the validity of maintaining separate categories for male and female athletes when factors such as internal testes and male-level testosterone production can provide significant advantages. The paragraph suggests that the conversation around fairness in sports must consider not only physical attributes but also the broader implications of including individuals with male-typical development in women's categories.

Mindmap

Keywords

💡Gender Verification Test

A gender verification test is a medical examination used to determine an athlete's eligibility for gender-specific sports categories. In the video, it is mentioned that Imane Khelif and Lin Yu Ting, two female boxers, had previously failed such a test, purportedly revealing they were 'biologic men.' This sparked controversy and debate over fairness in women's sports.

💡Performance-Enhancing Advantage

The term 'performance-enhancing advantage' refers to any unfair advantage an athlete might have over others due to biological, medical, or technological means. The video discusses speculation about whether the boxers in question have such an advantage, questioning if they are biologically male and thus have an unfair edge in women's boxing.

💡Biological Male

A 'biological male' is an individual with male sex characteristics developed from the XY sex chromosomes. The video script raises questions about whether the athletes are biological males, which is significant because it pertains to their physical attributes and potential advantages in sports like boxing.

💡Chromosomal Analysis

Chromosomal analysis is a medical test that examines an individual's chromosomes for abnormalities or specific patterns that can indicate sex and genetic disorders. The script mentions that the boxers' test results revealed 'male karyotype,' which implies the presence of XY chromosomes typically found in biological males.

💡Testosterone

Testosterone is the primary male sex hormone responsible for the development of male reproductive tissues and other male sexual characteristics. The video discusses the role of testosterone in providing a potential advantage in sports performance, and how its levels are regulated in athletes, particularly in the case of Caster Semenya.

💡Androgen Insensitivity Syndrome (AIS)

Androgen Insensitivity Syndrome is a medical condition in which an individual with XY chromosomes is resistant to androgens, leading to partially or completely female physical characteristics despite having male genetics. The video uses AIS as an example of conditions that can affect an athlete's eligibility and performance in gender-specific sports.

💡5 Alpha Reductase Deficiency

5 Alpha Reductase Deficiency is a condition where the body lacks or has an insufficient amount of the enzyme 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT). The video explains that this deficiency can lead to ambiguous genitalia and potential performance advantages in sports if not properly addressed.

💡IOC (International Olympic Committee)

The International Olympic Committee is the governing body of the Olympic Movement and oversees the hosting of the Olympic Games. The video discusses the IOC's role in determining eligibility criteria for athletes and its stance on the participation of individuals like Imane Khelif and Lin Yu Ting in women's boxing.

💡Caster Semenya

Caster Semenya is a South African middle-distance runner who has faced significant scrutiny and controversy over her participation in women's sports due to her naturally high testosterone levels. The video uses her case to highlight the complexities of determining fair competition in sports based on biological sex.

💡Sex Development Disorders (DSDs)

Sex Development Disorders are a group of congenital conditions that affect the development of reproductive or sexual characteristics. The script discusses DSDs in the context of sports eligibility, noting how conditions like 5 Alpha Reductase Deficiency can lead to situations where an athlete's competitive advantage is questioned.

💡Non-Genomic Androgen Signaling

Non-genomic androgen signaling refers to the rapid effects of androgens that occur without the need for interaction with the androgen receptor or nuclear translocation. The video mentions this concept to illustrate that androgens can still have significant effects on an individual's physiology and performance, independent of their genetic makeup.

Highlights

Discussion on Imane Khelif and Lin Yu Ting's gold medal wins in Olympic women's boxing and the controversy surrounding potential performance-enhancing advantages due to biological male traits.

Both athletes were disqualified previously for failing a gender verification test, indicating they might be biological males.

An opponent of Imane Khelif quit mid-match, claiming she had never been hit that hard, raising questions about the impact of biological traits on performance.

The International Boxing Association (IBA) disqualified the athletes based on gender eligibility tests, asserting they had competitive advantages.

The IBA confirmed the presence of male karyotype in the athletes, which is typically associated with a male biological makeup.

The IOC and IBA have differing stances on the eligibility of these athletes, with the IOC insisting they were born and raised as women.

IOC's 2021 guidelines place responsibility on individual federations to determine eligibility criteria for transgender athletes.

Many sports have banned trans women from participating in women's categories entirely due to eligibility criteria.

The case of Caster Semenya, a middle-distance runner, is highlighted as a relevant precedent for discussions on fairness in sports.

Semenya has an intersex condition that results in male-level testosterone without full androgen receptor sensitivity.

The history of sex verification in the Olympics and the shift from genetic testing to hormone level cutoffs is discussed.

Different disorders of sex development (DSDs) and their impact on an athlete's performance are examined for their complexity.

The role of androgen receptors and sensitivity in determining muscle growth and athletic performance is explained.

Non-genomic effects of androgens, which can impact performance independently of the androgen receptor, are highlighted.

The debate over the fairness of allowing athletes with certain DSDs to compete in women's categories without strict criteria is critiqued.

The need for clear and fair eligibility criteria in women's sports, especially given the potential for significant biological advantages, is emphasized.

The controversy is framed as an issue of privacy and fairness, where the lack of transparency in testing and criteria can lead to uncertainty.

Transcripts

play00:00

sup guys Derek more plates.com today we

play00:02

are touching on imane khif and Lin

play00:06

yuting and their gold medal wins in

play00:08

Olympic women's boxing and my analysis

play00:11

of the current situation is there a

play00:13

performance-enhancing Advantage is it

play00:15

literally what people are speculating it

play00:17

to be where there are biologic men

play00:20

making it into the Olympics competing

play00:23

against women and fighting them and

play00:24

punching them in the head like that is

play00:26

what a lot of the internet has run with

play00:29

and and I feel like there's a lot of

play00:31

missing information though which I hope

play00:33

to at least elucidate to give more uh

play00:36

takeaways that could be informative for

play00:38

the situation and kind of give my stance

play00:40

on it so basically these two individuals

play00:43

have uh been disqualified previously

play00:46

last year for failing a gender

play00:49

verification test where purportedly they

play00:52

were verified to be bogic men it seems

play00:55

like the immane situation has gotten a

play00:58

lot bigger though in that despite the

play01:01

fact that they have a pretty similar

play01:03

situation they both were disqualified

play01:04

for the same thing imman had one of I

play01:08

forget which round it was but one of one

play01:09

of the opponents basically quit

play01:11

mid-match because she claimed she has

play01:13

never been hit that hard in her life so

play01:16

in the middle of the Olympics literally

play01:18

just throwing in the towel midf fight

play01:20

cuz you've never been hit that hard and

play01:22

then this individual comes out shortly

play01:24

after that they failed a gender

play01:26

verification test and they've been

play01:28

disqualified Within you know the last

play01:30

year from competing the internet went

play01:32

absolutely haywire and objectively both

play01:35

of these individuals Lynn and immane

play01:37

look more masculine than most females

play01:39

like we can say with relative certainty

play01:42

that most people would agree that they

play01:44

look a little bit more masculine than

play01:46

the average female so all of these

play01:48

factors together you know it's a [ __ ]

play01:50

storm so immane and Lynn as far as I

play01:53

know have never identified as

play01:55

transgender or intersex but they failed

play01:57

a gender eligibility test at the 202

play01:59

three World Championships according to

play02:01

the international boxing Association IBA

play02:04

leading to disqualification and another

play02:07

test was conducted by the IBA to

play02:10

reconfirm the findings of the first test

play02:13

which it did according to the June 2023

play02:16

letter the IBA sent to the ioc which is

play02:19

the Olympic Committee so the IBA issued

play02:21

an official statement asserting that the

play02:23

women did not meet the required

play02:25

necessary eligibility criteria that were

play02:27

found to have competitive advantages

play02:29

over other female competitors however

play02:32

the IBA which organized the World

play02:34

Championships but is no longer

play02:36

Associated and involved with the

play02:37

Olympics would not initially reveal why

play02:41

they failed their test what was the

play02:43

criteria they did not meet at a press

play02:45

conference literally within the last

play02:47

week on August 5th the IBA which no

play02:50

longer oversees Olympic boxing

play02:52

apparently for concerns about its

play02:54

integrity and links to Russia and some

play02:56

other stuff take from that what you will

play02:58

finally clarified that khif and Lyn's

play03:00

test results revealed chromosomes that

play03:03

made them ineligible to compete in the

play03:05

women's category so the results summary

play03:07

were abnormal and the interpretation was

play03:11

chromosomal analysis reveals male karot

play03:14

type and they both had the same results

play03:16

a male kot type means the general

play03:18

appearance of an individual's complete

play03:20

set of chromosomes is that of a male and

play03:21

this can be assessed photographically

play03:24

you can see a depiction of the XY

play03:26

chromosomes through lab test results and

play03:28

this is supposedly what happened so this

play03:30

is a quote the problem was not with the

play03:32

level of khalif's testosterone because

play03:34

that can be adjusted nowadays but with

play03:35

the result of the gender test which

play03:38

clearly revealed that the Algerian boxer

play03:40

is biologically male this is apparently

play03:44

a total of five boxers had been examined

play03:46

including khif by the IBA and all of

play03:48

them were indeed men so Umar kremlev the

play03:52

ib's president then claimed that khif

play03:54

and Lyn's test results showed very high

play03:57

levels of testosterone now it's been

play03:59

unclear if blood test was actually

play04:02

conducted assessing testosterone levels

play04:03

for the purposes of assessing gender

play04:07

classification but even if it wasn't

play04:09

because there's a lot of stuff being

play04:10

thrown out right now as to you know did

play04:12

this stuff actually happen testosterone

play04:13

levels should be analyzed regardless um

play04:16

this isn't like for gender verification

play04:18

purposes necessarily but just straight

play04:19

up any governing body should know if an

play04:22

athlete's testosterone levels look male

play04:23

or not via the biological passport data

play04:27

that they should otherwise be collecting

play04:30

via their water accredited steroidal

play04:32

module so everybody in highle sport

play04:35

basically any athlete that is subject to

play04:37

drug testing would under you know water

play04:40

guidelines would have a water accredited

play04:43

biological passport that shows

play04:44

longitudinal data assessing their

play04:46

Androgen levels and metabolites and the

play04:48

ratios of them and absolute values for

play04:50

uh excretion patterns and whatnot so

play04:53

everyone Hazard testostrone tested via

play04:55

the steroidal module of the biological

play04:57

passport this is like the most basic of

play04:58

testing that should be collected among

play05:01

all athletes so they should already have

play05:03

the answer as to if these individuals

play05:05

have male looking testosterone levels or

play05:07

not as should the the Olympics you know

play05:10

the governing body should know this

play05:12

already they just may not otherwise want

play05:15

to disclose as far as exclusionary

play05:17

criteria that the technical and

play05:20

competition rules that apply to the IBA

play05:21

are obviously quite different than that

play05:24

of the ioc you know last year these

play05:26

individuals couldn't compete at the

play05:27

World Championships because of these

play05:29

verific tests via chromosomal analysis

play05:33

whereas in the Olympics that is not

play05:35

happening nor are they taking those

play05:38

tests into consideration whatsoever and

play05:40

apparently neither are testosterone

play05:42

tests being done or to the extent that

play05:45

they're not being considered for

play05:47

exclusionary criteria so the ioc has

play05:50

insisted the fighters were born and

play05:52

raised women but the IBA has continued

play05:55

to insist its test suggest their

play05:58

eligibility for women's boxing Ians in

play06:00

question so IBA doesn't think they

play06:02

should compete ioc thinks they should

play06:03

and people should leave them alone kind

play06:05

of a debacle so what is the ioc's

play06:07

position on eligibility for women's

play06:09

sports so this is you know I got

play06:11

interested because I've seen over the

play06:13

years the goal post being moved in

play06:14

multiple different sports and

play06:16

disciplines depending on how much

play06:18

scrutiny is happening transgender

play06:20

athletes that have basically worked

play06:22

their way into certain Sports and again

play06:25

by the way to clarify this is not a

play06:26

transgender situation this is different

play06:29

but but notably a lot of these rule

play06:31

changes have kind of happened in light

play06:33

of some of those like big time

play06:35

situations that you're probably really

play06:37

familiar with if this kind of content

play06:39

interests you at all you know like the

play06:40

Laurel hubard situation the cyclist the

play06:43

rugby players like there's a lot of

play06:44

stuff we've covered on this channel um

play06:46

and also the Caster smania situation

play06:48

which we'll get into shortly as well

play06:50

because it's highly relevant here so in

play06:52

late 2021 the ioc issued new guidance on

play06:56

transgender athletes in women's sport

play06:58

this placed the responsibility on

play07:00

individual federations to determine

play07:02

eligibility criteria in their Sport and

play07:04

since then many sports have banned trans

play07:07

women from taking part in women's sport

play07:09

entirely such as Athletics Aquatics and

play07:12

rugby codes as well tracks World

play07:14

Athletics tighten the eligibility rules

play07:16

for female athletes with DSD conditions

play07:18

so testosterone levels now being used to

play07:21

assess eligibility not XY chromosomes

play07:25

which is the pattern typically seen in

play07:27

men are the key Criterion of of

play07:29

eligibility in Olympic events where the

play07:31

sports governing body has framed and

play07:33

approved rules and starting in March of

play07:35

2023 it required them to suppress their

play07:37

testosterone levels to 72 nanograms per

play07:40

deciliter for 6 months typically through

play07:42

hormone suppressing treatment

play07:45

anti-androgens to be eligible to compete

play07:47

so for contacts the average woman will

play07:50

typically have a total testosterone

play07:52

level between 13 and 71 n per deciliter

play07:55

so 72 it's not like you're at the bottom

play07:57

of the Barrel in production and you are

play08:00

literally on the threshold of arguably

play08:03

too high as is it's a generous I would

play08:06

say cut off depending on your response

play08:09

to those hormones which is where we get

play08:10

into some of these very unique medical

play08:12

conditions so anyways 72 NS per

play08:15

desolator remember that it's the top of

play08:16

the female range that is the cut off

play08:18

that they have and you can understand

play08:20

how they ared there at least you know if

play08:22

they have to come up with something it

play08:23

kind of makes sense how they arve there

play08:25

it used to be 10 animals per liter which

play08:27

is like I think 288 nanograms per deer

play08:31

and then it was dropped to five nimals

play08:33

and then now it's 2.5 in a lot of these

play08:35

Sports World Aquatics prohibited trans

play08:37

women from competing in women's races if

play08:39

they had undergone male puberty that was

play08:41

their you know Line in the Sand

play08:43

International cycling Union also took

play08:45

this step last year the swim B's World

play08:48

leading rules additionally required

play08:50

transgender women athletes who did not

play08:53

undergo male puberty to maintain

play08:54

testosterone levels below the 72

play08:56

nanogram per destillat cut off however

play08:59

this where things get complicated the

play09:01

rules have been applied differently so

play09:02

there are Sports in which trans women or

play09:05

athletes with differences of sex

play09:07

development DSD I probably should have

play09:09

mentioned what DSD was earlier can

play09:11

compete boxing is one of those as the

play09:14

ioc which has been overseeing Olympic

play09:16

boxing hasn't updated their eligibility

play09:18

criteria rules and literally the

play09:21

criteria of Eligibility this year was

play09:23

based on their passport saying they're

play09:26

female apparently so the ioc said it

play09:28

supports the participation of any

play09:30

athlete who has qualified and met the

play09:31

eligibility criteria to compete in the

play09:33

Olympic Games as established by their

play09:36

International Federation the ioc will

play09:38

not discriminate against an athlete who

play09:40

is qualified through their International

play09:42

Federation on the basis of their gender

play09:44

identity and or sex characteristics so

play09:48

you know Troublesome as you can imagine

play09:50

let's talk about Caster smania I think

play09:51

that is probably the most prime example

play09:54

of a gold medal caliber athlete who

play09:56

underwent similar levels of scrutiny all

play09:59

but in a different event but in a in a

play10:01

much less private way but I think it

play10:03

gave a lot of insight into how these

play10:06

situations are handled is there a

play10:08

performance enhancing advantage or not

play10:10

like outside of the whole ethics

play10:12

discussions like all this stuff like at

play10:14

the end of the day we do ultimately want

play10:16

to know are individuals with these

play10:18

unique predispositions in a uniquely

play10:21

advantaged position competing against

play10:24

women the Castor Sania situation I think

play10:26

is most relevant to discuss in that uh

play10:29

pter basically learned of uh how her

play10:33

Anatomy differs from the typical woman

play10:36

she is competing against and what

play10:37

implications that has for performance as

play10:39

did the public which was unfortunate for

play10:42

her that it was such a public you know

play10:43

display of what's going on with her body

play10:45

it's like very embarrassing I can just

play10:47

imagine the stress especially when

play10:48

you're born a certain way certain way

play10:50

you have no say in it you would just you

play10:52

know you could be living your entire

play10:54

life thinking you are just a normal

play10:57

healthy functioning very very muscular

play11:00

women and in reality you have like a

play11:02

unique situation that is not really in

play11:06

parody and fairness to your you know

play11:09

female competitors so let's get into it

play11:11

so basically prime example she you know

play11:14

gold medal athlete a lot of scrutiny

play11:16

very public situation messy situation

play11:19

she is a South African middle distance

play11:21

Runner and winner of two Olympic gold

play11:23

medals and three World Championships in

play11:24

the women's 800 meter following sania's

play11:27

victory at the 2009 World Champion ship

play11:29

she was made to undergo sex testing and

play11:32

cleared to return to competition the

play11:33

following year the decision to perform

play11:35

this testing was pretty controversial

play11:37

you know as far as I know they weren't

play11:39

really doing this like in the 90s they

play11:41

basically stopped testing with uh for

play11:44

gender which we'll get into shortly but

play11:46

basically sparked a lot of controversy

play11:48

and later reports disclose that Sania

play11:50

has the interex condition 5 Alpha

play11:52

reductase to deficiency and male level

play11:55

natural testosterone levels you know

play11:57

pretty a startling discovery

play11:59

especially if you had no idea going your

play12:01

whole life thinking that you know you're

play12:04

just uh uniquely advantaged but you

play12:06

don't realize you have what we're going

play12:08

to get into shortly is uh internal

play12:11

testes so in 2019 new

play12:14

I World Athletics rules came into Force

play12:17

for athletes like Sania with certain

play12:19

disorders of sex development DSD is

play12:21

requiring medications to suppress

play12:23

testosterone levels in order to

play12:24

participate in the 400 meter 800 meter

play12:26

and 1500 meter women's events Sania

play12:29

refused to undergo the treatment which

play12:31

is now mandatory and has filed a series

play12:33

of legal cases to restore her ability to

play12:35

compete without testosterone suppression

play12:38

arguing that the rules are

play12:40

discriminatory in March 2023 World

play12:42

Athletics made its rules for sanan and

play12:44

other DSD athletes even more restrictive

play12:46

requiring them to lower their test

play12:48

levels below a threshold of 72 nags per

play12:51

Deiter for 2 years before competing so

play12:53

it's getting more and more strict

play12:54

depending on the event as we'll see

play12:56

although Sania was assigned female at

play12:58

Birth she has the intersec condition I

play13:00

mentioned 5alpha reductase 2 deficiency

play13:03

and this condition only affects genetic

play13:05

males with XY chromosomes individuals

play13:08

with this deficiency have normal male

play13:10

internal structures that are not fully

play13:12

masculinized during the development of

play13:14

the reproductive system in Udo due to

play13:16

the low levels of DHT that would

play13:18

otherwise be produced via this enzyme

play13:20

that is absent in activity essentially

play13:23

and as a result the external genitalia

play13:25

may appear ambiguous or female at Birth

play13:28

Caster Sania has said that she was born

play13:30

with a vagina and internal undescended

play13:33

testes but she has no uterus oral opian

play13:36

tubes and does not menstruate being born

play13:38

you know without utrus you know being

play13:40

born with internal testicles those don't

play13:43

make me less a woman her internal teses

play13:45

produce natural testosterone levels in

play13:47

the typical male range so obviously a

play13:50

problem there for fairness at least you

play13:54

know a pretty uh highly debated

play13:56

situation and nowadays highly relevant

play13:59

given the current situation so now

play14:01

moving on to history of sex verification

play14:03

in the Olympics how do they actually

play14:05

screen for the stuff back in the day and

play14:07

how do they do it now or do they so the

play14:10

sex of an individual is usually

play14:12

determined by a pair of sex chromosomes

play14:14

typically females have two of the same

play14:16

XX sex chromosomes males have two

play14:19

different kinds of sex chromosomes XY Y

play14:21

chromosome is responsible for triggering

play14:23

male development and the absence of the

play14:26

Y chromosome the fetus will undergo

play14:28

female development you probably heard

play14:29

that we all start as females like this

play14:31

is kind of what they're referring to

play14:33

there are various rare exceptions though

play14:35

which is what makes this really really

play14:36

complicated so a single sex determining

play14:39

region y protein called Sr y you might

play14:42

have heard of this if you've been

play14:43

following the situation this sry y Gene

play14:46

being present on the Y chromosome acts

play14:48

as a signal to set the developmental

play14:51

pathway towards masculinization and

play14:53

mutations in this Gene lead to a range

play14:56

of disorders of sex development with

play14:57

varying effects on an individual's

play14:59

phenotype and genotype and one of the

play15:01

most controversial uses of this Gene was

play15:04

as a means of sex verification in the

play15:06

Olympics under a system implemented by

play15:09

the ioc in 1992 so athletes with an Sr y

play15:15

Gene were not permitted to compete as

play15:17

females although you know many of them

play15:19

might be assigned female at Birth if

play15:22

they had this gene they were essentially

play15:23

told you know you're a man and you can't

play15:26

compete now at the 96 Summer Olympics

play15:29

apparently all the athletes in which

play15:31

this was detected were ruled false

play15:34

positives and were not disqualified

play15:36

specifically eight female participants

play15:38

out of a total of

play15:40

3,387 at these games were found to have

play15:42

this Gene however even though they have

play15:45

this Gene after further investigation of

play15:48

their genetic conditions all these

play15:49

athletes were verified as female and

play15:51

allowed to compete so these athletes

play15:53

were found to have either partial or

play15:56

full Androgen and sensitivity despite

play15:58

having an Sr y Gene making them

play16:00

externally phenotypically female and in

play16:03

the late '90s a number of relevant uh

play16:06

professional Societies in the US called

play16:08

to eliminate this gender verification

play16:10

thought it was ineffective and um

play16:14

seemingly unethical and basically it was

play16:17

eliminated by the 2000 Summer Olympics

play16:19

and this was followed with the new

play16:21

implementation of hormone level cut offs

play16:24

as a means of assessing you know are

play16:26

You2 male essentially now you're going

play16:28

to you can just imagine how this gets

play16:30

really complicated because if you were

play16:31

somebody who like by via an analysis

play16:34

have been determined that you were meant

play16:36

to go down a developmental pathway that

play16:39

is biologically male but you otherwise

play16:41

have a mutation in the gene that encodes

play16:43

for you know five Alpha reductase or you

play16:46

have Androgen receptor and sensitivity

play16:48

so you don't actually respond to the

play16:49

androgens to actually masculinize to

play16:51

whatever severity the Androgen receptors

play16:53

are actually functional or dysfunctional

play16:55

you have a spectrum of sexuality

play16:57

essentially whereby individuals may have

play16:59

partial viralization complete lack of

play17:02

viralization or otherwise like totally

play17:05

female essentially with exception of

play17:08

their like genetic makeup it all is a

play17:11

spectrum and that's what we're going to

play17:12

get into now is the actual performance

play17:13

enhancing Advantage is there one so for

play17:15

Iman khif and Lynn you know the

play17:18

situation seems cut and dry if you have

play17:20

XY chromosomes and a functional Sr y

play17:22

Gene which is what we can discern from

play17:24

the test of you know the IBA a lot of

play17:27

people are saying you shouldn't compete

play17:28

against swim in full stop that's what a

play17:30

lot of people will say and I totally

play17:31

understand why they would conclude that

play17:33

however what muddies the waters on this

play17:36

is the huge difference in how different

play17:38

categories of dsds and conditions can

play17:41

impact not just your synthesis capacity

play17:43

of androgens like how much you can

play17:45

actually make are your testes actually

play17:47

functional do you actually have them

play17:48

still because a lot some of these

play17:49

individuals end up getting gonadectomies

play17:52

like we're going to get into it all but

play17:53

in addition like Baseline it's

play17:55

anatomical infrastructure and the

play17:58

spectrum of how you respond to those

play17:59

hormones so in the case of Castro Mania

play18:02

we know the condition in question was

play18:03

the specifically five Alpha reductase

play18:06

deficiency so let's get into that first

play18:08

because I think this is the most ideal

play18:10

example of a situation in which an

play18:12

individual who otherwise is genetically

play18:16

on the path to becoming a man deviates

play18:19

from a deficiency in well a mutation in

play18:22

the gene that encodes for an enzyme that

play18:24

is responsible for the production of the

play18:26

male main androgenic hor hormone that

play18:29

dictates male sexual differentiation and

play18:31

maturation in adolescence but retains

play18:34

male advantages via their inherent

play18:36

testosterone so this is like on one side

play18:38

of the spectrum a condition in which

play18:41

this individual probably at least in my

play18:44

opinion has a significant Advantage

play18:46

pending their testes are

play18:48

infrastructurally sound enough to

play18:50

produce male amount of hormones and this

play18:52

is where again the imperfect

play18:54

testosterone test is absolutely not an

play18:57

ideal way to go about having

play19:00

exclusionary criteria or whatever when

play19:02

some of these individuals actually have

play19:04

complete absence of response at the

play19:06

Androgen receptor which we'll get into

play19:08

too but first let's get into this

play19:09

example because I think it's the most

play19:10

relevant to kind of set the stage here

play19:12

so Caster who asserts you know it

play19:14

doesn't matter what I have my uh what

play19:16

I'm born with I'm a female you know it's

play19:18

fine let me compete so basically Caster

play19:21

situation is a deficiency in this five

play19:24

Alpha reductase enzyme activity where

play19:27

and this is literature back you can you

play19:30

know double check what I'm saying

play19:31

basically genetic males with male gonads

play19:34

do not produce enough DHT because they

play19:36

have a mutation in the SRD 582 Gene so

play19:39

this mutation prevents five Alpha

play19:41

reductase from converting testosterone

play19:43

into DHT adequately

play19:46

dihydrotestosterone the most androgenic

play19:48

hormone in the body responsible for an

play19:52

array of things but the most notable

play19:55

being sexual differentiation and

play19:57

maturation

play19:59

masculinization so depending on the

play20:01

severity of their deficiency which

play20:03

notably is a spectrum because again this

play20:05

mutation in the gene it's not just like

play20:08

you completely lack the capacity to make

play20:11

DHT some individuals they need to be

play20:13

diagnosed via a threshold ratio of

play20:15

testosterone to DHT or literal analysis

play20:18

of their genitalia so males with five

play20:21

Alpha reductase deficiency can be born

play20:23

with genitalia that is not obviously

play20:25

male or female it's ambiguous in some

play20:27

cases their gen Alia appears female or

play20:30

in other cases they definitively have

play20:32

male genitalia but it is unusually small

play20:35

so micropenis with the urethra opening

play20:38

on the underside of the penis and during

play20:40

puberty testosterone and DHT Spike

play20:42

significantly now in general this would

play20:44

be when individuals undergo full-blown

play20:47

puberty and totally mature into adult

play20:50

men so circulating levels of total DHT

play20:53

or about 1/10th the concentration that

play20:55

of total testosterone but local

play20:57

concentrations of DHT can be up to 10

play21:00

times higher than testosterone in

play21:02

specific areas of the body to facilitate

play21:05

full maturation we can get into you know

play21:08

the chemistry on that and some of the uh

play21:10

interesting tidbits and I'm highly

play21:12

tempted to do so but I feel like I'm

play21:14

going to derail the entire video but

play21:15

basically what you need to know is DHT

play21:17

is in bioassays equivalent to 2.5 to 10

play21:21

fold more potent than testosterone at

play21:23

the Androgen receptor it's so androgenic

play21:25

that even though it is you know present

play21:27

at least systemic obviously tissue

play21:29

specific is different like overall

play21:31

concentrations of it in the body are a

play21:33

fraction of that of testosterone is

play21:35

still the primary hormone responsible

play21:37

for the development of secondary sex

play21:40

characteristics like deepening of the

play21:41

voice development of facial hair body

play21:43

hair growth of the penis and scrotum or

play21:45

it's at least

play21:47

significantly implicated in reaching

play21:50

full maturity perhaps is a more accurate

play21:52

statement so during puberty men with

play21:55

deficiency in this enzyme do not develop

play21:57

much facial hair body hair notably no

play22:00

androgenic alopecia and this is kind of

play22:01

the Inception of some of these uh hair

play22:03

loss prevention drugs which operate via

play22:06

the senz pathway but anyways and they

play22:07

also have a small prostate many males

play22:09

with 5 AR deficiency are actually raised

play22:13

as female until they hit puberty because

play22:15

they didn't have enough DHT to markedly

play22:17

differentiate themselves as males pre

play22:19

puberty so they were born appear to be

play22:22

female and then you know when they hit

play22:24

puberty all of a sudden the spike in

play22:25

testosterone makes it a bit more obvious

play22:27

that things are not like classically

play22:31

female once they hit puberty and test

play22:32

level Spike the penis and other Androgen

play22:34

supported structur start to enlarge and

play22:38

but still without the DHT you don't end

play22:40

up having full maturation penis doesn't

play22:42

grow to full size like it would um

play22:44

facial hair doesn't develop prostate

play22:46

growth doesn't happen as much Etc so

play22:49

most notable though about this is the

play22:51

fact that with DHT deficiency with

play22:53

intact testes and male testosterone

play22:55

levels you will still have male levels

play22:57

of performance undoubtedly so with this

play23:00

condition the gonads can still function

play23:01

and produce male levels of testosterone

play23:03

and androgen receptors are fully

play23:06

functional meaning you get male levels

play23:08

of bone mass muscle mass General

play23:10

anabolic activity arthr poesis you know

play23:13

it's not the arthop pois is still going

play23:14

to be driven through DHT too but like if

play23:16

you have male level testosterone you

play23:18

were getting all of the anabolic

play23:20

activity that a male would have with

play23:22

those levels so despite being a more

play23:24

potent Androgen unlike testosterone DHT

play23:27

is inactivated by the enzyme three Alpha

play23:30

hydroxysteroid dehydrogenase 3 Alpha hsd

play23:33

in muscle via its conversion into a very

play23:36

weak Androgen known as three Alpha

play23:39

andran dial so basically DHT is present

play23:43

in specific tissues to drive sexual

play23:45

differentiation and maturation but does

play23:47

almost nothing for muscle growth and

play23:49

this is very apparent in male

play23:51

pseudohermaphrodites who are inherently

play23:53

five Alpha reductase deficient due to

play23:55

genetic mutations so here's an example

play23:58

one one study involving Brothers with

play23:59

different DHT levels the male with

play24:01

partial this is partial by the way five

play24:04

Alpha reductase deficiency experienced

play24:06

reduced sexual development throughout

play24:08

puberty but actually gained more muscle

play24:10

mass than his brother this is a picture

play24:12

of them together the man on the left has

play24:14

a five Alpha reductase deficiency and

play24:16

his brother on the right doesn't have a

play24:17

deficiency the man on the left has a

play24:19

higher testosterone level so you heard

play24:22

correct higher and is more muscular and

play24:24

has less androgenic alpia than his

play24:26

brother on the right who has normal DHT

play24:28

level so like you know they look both

play24:30

like males and one has some of the you

play24:34

know Hallmarks of natural male

play24:37

development whereby they sort have

play24:39

temporal recession Etc but the male with

play24:41

higher test levels and 5 AR deficiency

play24:44

still has you know development as a male

play24:46

just not to this degree that they would

play24:49

have otherwise with adequate DHT but

play24:50

notably the biggest takeaway in my

play24:52

opinion on that is normal muscle so male

play24:55

level muscle tissue in response to the

play24:57

male Androgen testosterone that you were

play25:00

producing so even in studies when this

play25:02

is you know fully wiped out like almost

play25:05

essentially manually replicating what is

play25:08

you know the Castro Mania situation more

play25:10

or less depending on the actual

play25:12

structural Integrity of what her uh

play25:16

goads were capable of producing

play25:17

testosterone wise which sounds like you

play25:19

know it was male territory level still

play25:21

ultimately in studies where adults have

play25:23

their DHT levels completely wiped out

play25:25

with a nuclear level 5 Alpha reductase

play25:27

inhibiting drug called dutasteride at

play25:29

2.5 milligrams a day which can wipe out

play25:32

upwards of 98% of systemic DHD if I

play25:35

recall correctly these participants did

play25:38

not experience hindered muscle growth at

play25:41

all and personally I've actually been on

play25:42

dutasteride myself for hair loss

play25:44

prevention and despite having lower test

play25:46

or lower DHT levels than a girl it has

play25:49

absolutely zero impact on anything

play25:51

perceivable that I've noticed except for

play25:53

a bit less back hair now and I don't

play25:55

lose my scalp hair as fast now so

play25:57

testosterone pulls the weight from an

play25:59

anabolic standpoint uh just fine so for

play26:02

someone to have a 5 AR deficiency as

play26:04

they grow up it will prevent them from

play26:06

going through puberty and fully

play26:07

masculinizing but they still have fully

play26:09

functioning Androgen receptors and their

play26:11

body will still masculinize to the

play26:13

capacity that their natural male level

play26:16

testosterone levels will allow which is

play26:18

contingent on the functional capacity of

play26:20

their testes which will vary but you

play26:22

know ultimately individuals regardless

play26:24

if they have full 5 AR deficiency or

play26:26

partial and again like cter I believe it

play26:29

was just only deficiency in the type 2

play26:32

isozyme if I recall correctly you know

play26:34

the dutasteride example I gave inhibits

play26:36

all three isozymes which is basically

play26:39

every type of enzyme that 5 Alpha

play26:43

reduces testosterone to DHT is

play26:45

completely nuked into nothingness

play26:47

through irreversible inhibition at a Max

play26:49

dose you have probably this same or

play26:52

lower DHD levels in Castro Mania you

play26:55

have no inhibited muscle like these

play26:56

individuals in these studies it's a

play26:58

highly replicated and repeatable and

play27:01

predictable finding that DHD inhibition

play27:03

does not really impact muscle growth

play27:05

capacity at all so we don't have enough

play27:09

information though to say this is what

play27:11

Iman khif and linu have so like with

play27:14

Caster it was literally analyzed

play27:16

identified and specified to a degree

play27:20

that you knew exactly what was going on

play27:22

you saw the functional capacity of

play27:24

Caster's testes male level testosterone

play27:27

levels there was no andro receptor and

play27:28

sensitivity the only thing that was

play27:30

going on was there was a lack of DHT

play27:32

that basically resulted in a growing up

play27:36

appearing to be female and then not

play27:38

having full sexual differentiation and

play27:40

maturation that somebody with adequate

play27:42

DHT production would otherwise have but

play27:44

still getting the benefits of a male

play27:45

from a testosterone and androgen

play27:47

receptor standpoint so what's going on

play27:49

with Iman a however you pronounce that

play27:52

imane and Lynn we don't have enough

play27:54

information to say and it sounds like

play27:55

they might not either but again this

play27:58

this is why I wanted to elucidate the

play28:00

five Alpha reductase deficiency

play28:02

specifically because this is one of

play28:04

these conditions that could result in

play28:05

somebody who is growing up with what is

play28:09

essentially female seemingly Anatomy but

play28:14

has the performance-enhancing advantage

play28:16

of being a man that is one extreme

play28:19

example now here are some other ones

play28:21

which get a bit more complicated so

play28:23

there are other categories of dsds and

play28:26

conditions arising from different gen

play28:28

mutations enzyme deficiencies or an

play28:30

array of different things that could

play28:31

appear on paper to be just as unfair you

play28:34

know your XY you've had this uh the SR y

play28:37

Gene Etc you know you could fail a sex

play28:39

verification test but in the same manner

play28:42

but not actually get a Advantage even

play28:45

comparable to castania so for example

play28:48

this is documented in literature five

play28:50

Alpha reductase type two isozyme

play28:52

deficiency can be difficult to

play28:54

distinguish and the the reason I

play28:56

specified type two is because this is

play28:57

the one that can actually lead to a

play29:00

situation in which somebody has

play29:02

deficiency and DHD significant enough to

play29:04

create a um like ambiguous gender upon

play29:09

pre-adolescence so the other isozymes

play29:11

are not as impactful on sexual

play29:14

differentiation maturation because 5 AR

play29:16

type two basically pulls the line share

play29:19

when it comes to tissue conversion of

play29:21

DHT to drive masculinization so anyway

play29:25

just a side note it is the type 2

play29:26

deficiency in particular that actually

play29:28

leads to a 46xy DSD looking situation so

play29:33

5 AR type 2 deficiency can be difficult

play29:37

to distinguish though from other causes

play29:39

of 46xy DSD like partial Androgen and

play29:44

Sensitivity Syndrome for example 17 beta

play29:47

hydroxy steroid dehydrogenase type 3

play29:49

enzyme deficiencies among other things

play29:52

so if you didn't use blood work to

play29:53

analyze testosterone to DHT ratios and

play29:56

use precise anatomical Imaging you would

play29:58

actually find that and by the way also

play30:00

bone density muscle mass is always going

play30:02

to be greater in individuals with the 5

play30:04

AR type D deficiency in contrast to 46

play30:08

XY DSD from other causes like partial

play30:10

Androgen and sensitivity and the enzyme

play30:12

deficiency I just mentioned because the

play30:14

different net impact on Androgen

play30:16

mediated transcriptional activity of the

play30:18

receptor at the receptor itself is is

play30:20

just not the same so the net outcome

play30:23

despite having you know XY chromosomes

play30:26

also high levels of testosterone a

play30:27

function sry Gene even if you are

play30:30

externally phenotypically female it's

play30:32

entirely possible that an individual

play30:34

could have partial or complete Androgen

play30:37

and sensitivity so the reason I kind of

play30:39

brought up this comparison to begin with

play30:41

is as I mentioned the 5 AR type 2

play30:43

deficiency can be difficult to

play30:45

distinguish from other causes when you

play30:47

just look at an individual they could

play30:49

undergo the same degree of

play30:52

masculinization but it's their lack of

play30:55

DHT and amount of testosterone that is

play30:58

push them to the point they're at of

play31:00

whatever spectrum of masculinization

play31:02

they're at whereas these other

play31:04

conditions they might have full capacity

play31:06

to produce DHT they might actually have

play31:08

high testosterone and DHT but the way

play31:09

they actually respond to those hormones

play31:12

puts them at a level that appears to be

play31:14

similarly masculinized to the 5 AR

play31:17

deficiency individual but this

play31:19

individual has the performance advantage

play31:20

of testosterone and no DHD or almost

play31:23

none so they basically are

play31:26

undervirilization

play31:28

anabolic capacity whereas this

play31:29

individual does not even have comparable

play31:32

anabolic like activity whatsoever to

play31:35

this individual but because of the DHT

play31:38

production whatever spectrum of Androgen

play31:41

sensitivity or other condition they have

play31:42

may put them at the same level as this

play31:44

like objectively from like a how far on

play31:47

the spectrum of masculine masculine are

play31:49

you the equated outcome on performance

play31:51

is just not the same so anyways

play31:53

hopefully I I'll get into more detail

play31:55

that hopefully helps uh make this a bit

play31:58

more I don't know it brings it home in

play32:00

some capacity so now let's talk about

play32:02

Androgen receptors and sensitivity an

play32:04

individual with this functional Androgen

play32:06

receptors May respond just enough to the

play32:09

amount of DHT present to partially

play32:11

masculinize as DHT is such a potent

play32:13

Androgen for driving masculinization and

play32:16

maturation but they may not be

play32:19

responsive enough to androgens as a

play32:21

whole to get any actual performance

play32:22

advantage over women but you know it's a

play32:25

spectrum some individuals with complete

play32:27

Androgen and sensitivity may be much

play32:29

worse off than somebody who has partial

play32:32

insensitivity likely will be and the

play32:34

person with complete insensitivity may

play32:36

be you know equivalent to the lack of

play32:39

advantages that women have relative to

play32:41

biologic men or maybe even worse off

play32:44

like you know I don't know it depends on

play32:45

the level the severity of which an

play32:48

individual has in insensitivity and the

play32:50

functional capacity of their testes to

play32:52

even make hormones you could have an

play32:54

individual with complete insensitivity

play32:56

that has poor testosterone production

play32:58

and is worse off than a natural totally

play33:02

healthy verile woman who has no

play33:07

inhibition to Androgen receptor activity

play33:09

or their natural testosterone production

play33:10

you know it would be like the equivalent

play33:12

to being on a nuclear level castration

play33:13

drug your entire life essentially if you

play33:15

were in that situation here's an example

play33:18

so this is something that can hopefully

play33:19

illustrate how convoluted this gets so

play33:21

bicalutamide probably means nothing to

play33:23

you but it is it is a non-steroidal

play33:26

antiandrogen so a lot of people have

play33:28

been talking about puberty blockers

play33:29

nowadays it's a big Topic in media and a

play33:33

understandably controversial one because

play33:35

individuals are getting it's a whole

play33:37

another video but anyways basically

play33:39

bicalutamide is a drug that can act as a

play33:41

puberty Blocker in transgender girls and

play33:44

it works quite well so hypothetically if

play33:47

a pre-adolescent male took a mega dose

play33:50

of bicalutamide to prevent

play33:52

masculinization that would occur via

play33:54

androgens interacting with the Androgen

play33:55

receptor basically this drug act as a

play33:58

non-steroidal um silent antagonist

play34:00

meaning it will occupy Androgen

play34:02

receptors and prevent DHD and

play34:04

testosterone from binding to it and

play34:05

doing what it does and you know it does

play34:07

this fairly well depending on the dose

play34:09

of bicalutamide let's say somebody's on

play34:10

a nuclear level dose in pre-adolescence

play34:13

they will actually have a higher

play34:14

testosterone level on paper than a male

play34:17

who is non-medicated but they won't

play34:19

actually get the effects of that

play34:20

testosterone and DHD the direct genomic

play34:23

effects of that Androgen in skeletal

play34:25

muscle bone and the Brain Etc they won't

play34:27

have that some individuals actually have

play34:29

higher testosterone levels as a

play34:31

compensatory mechanism because their

play34:33

body has suboptimal response at the

play34:35

Androgen receptor and needs more

play34:37

testosterone and DHT than another guy to

play34:40

achieve the same development or

play34:42

functionality as someone who could have

play34:44

you know half the testosterone levels

play34:46

this is why you know you'll often see

play34:47

individuals that are twice as jacked as

play34:49

somebody else but their levels on paper

play34:52

it doesn't mean that every person that

play34:53

has more muscle has more testosterone

play34:56

than the next guy like I know some of

play34:57

the most Jack guys I know have 500 to

play34:59

600 total T's whereas I know guys who

play35:01

have 900 plus naturally who are smaller

play35:06

you know sometimes it is a reflection of

play35:07

your body actually needs to produce more

play35:09

to get the same effect that somebody who

play35:12

is more sensitive to androgens could get

play35:14

at a lesser concentration so when

play35:17

individuals are inhibiting action at the

play35:20

receptor but have otherwise functioning

play35:22

testes they end up with higher

play35:24

testosterone levels on paper so an

play35:26

individual with in sensitivity to

play35:28

androgens May otherwise have higher

play35:31

hormone levels on paper but respond

play35:34

horribly to those hormones and not

play35:36

actually get the advantages that they

play35:37

would impart so you can see how this

play35:39

gets super complicated now so the lack

play35:41

of negative feedback in the brain

play35:42

results in in overcompensation stimulate

play35:46

as much as this is by camide research 2x

play35:49

the testosterone levels in the testes as

play35:51

a normal non-medicated male but the male

play35:53

on bicalutamide with double the test

play35:55

levels will not develop like the male

play35:58

with half the test levels with

play36:00

uninhibited Androgen receptors so you

play36:01

could like block puberty with this drug

play36:04

and have higher testosterone and DHT

play36:06

levels on paper despite the fact that

play36:08

you're actually blocking puberty and the

play36:10

effects of these hormones versus another

play36:13

guy who has less than half the Androgen

play36:15

levels go through puberty just fine

play36:17

because they're not competing at the

play36:19

receptor with this drug so individuals

play36:22

with a mutation in the gene that encodes

play36:24

for filling the blank and causes a

play36:27

defect in I don't know like Androgen

play36:29

receptors that are dysfunctional and are

play36:32

not functioning correctly to impart

play36:34

transcriptional activity this is a

play36:36

spectrum by which somebody would

play36:38

otherwise be able to potentially have

play36:41

higher hormone levels on paper but

play36:42

respond so horribly that they actually

play36:44

have a lesser Advantage than anybody

play36:46

else essentially who has you know has

play36:49

fractions of the hormones but proper

play36:51

response but it's a spectrum so let's

play36:53

get into that so the subcategories of

play36:55

Androgen receptor insensitivity these

play36:57

are critical in my opinion for the

play37:00

Nuance of this conversation when it

play37:02

comes to who should be allowed to

play37:04

compete ver not or just what male level

play37:07

Advantage Advantage does somebody

play37:10

potentially have so mild Androgen and

play37:12

Sensitivity Syndrome is indicated when

play37:14

the external genitalia are those of a

play37:17

typical male so a penis and a scrotum

play37:20

partial Androgen insensitivity syndrome

play37:22

this is as the name implies partial

play37:25

insensitivity to androgens at the

play37:26

receptor and this is the first category

play37:30

in which an individual is not obviously

play37:33

male this partial

play37:36

insensitivity is at a hindered athletic

play37:39

capacity in contrast to a 5 Alpha

play37:42

reductase deficiency individual like

play37:44

castania but they may have similar

play37:46

levels of masculinization so when the

play37:48

external genitalia is partially but not

play37:51

fully masculinized or is ambiguous

play37:53

entirely these individuals could

play37:55

otherwise depending on how responsive

play37:58

they are in actual production of

play38:00

hormones could be just as masculinized

play38:02

or lack thereof as somebody with a 5

play38:04

Alpha reductase deficiency but because

play38:06

of their insensitivity at the receptor

play38:08

their testosterone levels do not impart

play38:10

the same advantages that somebody with a

play38:12

5 AR deficiency does who has normal

play38:14

testosterone levels and full capacity to

play38:16

impart transcriptional activity via the

play38:18

testosterone at the receptor level now

play38:21

the next most extreme version of

play38:23

insensitivity is complete Androgen

play38:25

insensitivity syndrome this is indicated

play38:27

when the external genitalia are those of

play38:29

a typical female vulva now obviously

play38:33

these are three categories and as you

play38:35

can imagine there's a spectrum within

play38:37

these three categories by which things

play38:39

get as if it wasn't complicated enough

play38:42

even more complicated because it's like

play38:43

the identifi identification of this can

play38:46

be like highly scrutinized as to how

play38:49

which of these you you fall into as an

play38:51

individual so hormone levels have been

play38:53

reported in Gat intact individuals with

play38:56

complete and Androgen and Sensitivity

play38:58

Syndrome in a number of studies which is

play39:00

notable because it really calls into

play39:02

question the Credence of these

play39:03

testosterone threshold values to begin

play39:05

with in Olympic testing and these

play39:07

individuals hormone levels are similar

play39:09

to those of males High test levels

play39:11

relatively low estradi levels but

play39:14

expectedly even with those high

play39:15

testosterone levels complete Androgen

play39:18

and sensitivity syndrome is associated

play39:19

with decreased bone mineral density and

play39:21

muscle mass in contrast to healthy

play39:24

unaffected biological males and bone and

play39:27

muscle Mass expectedly you know these

play39:29

categories the higher up on the uh

play39:33

categorical classification you are from

play39:35

complete to partial to mild the more

play39:37

mild it is the closer your bone and

play39:40

muscle mass will be reflective of that

play39:42

of a normal biologic male with no issues

play39:46

at the receptor that is probably logical

play39:48

most people would assume that to be

play39:49

logical but it's worth noting Ness now

play39:52

some of the anatomical differences

play39:54

between genders I think most are

play39:56

probably familiar with the fact that

play39:57

there's obvious differences here and as

play40:00

you would expect on the spectrum of

play40:03

masculinization vers maintaining full

play40:07

femininity you will have differences in

play40:09

how somebody develops in terms of

play40:12

anatomical advantages so individuals

play40:15

with Androgen and sensitivity are

play40:18

typically going to be taller slightly

play40:20

longer Limbs and larger hands which

play40:22

obviously could be advantageous when

play40:24

punching somebody in a boxing ring also

play40:26

lung volumes will differ so on the

play40:29

extreme you have female versus male

play40:32

there's a difference of 10 to 12% in

play40:34

lung volume with females having 10 to

play40:36

12% smaller lung volumes than males and

play40:38

depending on the spectrum of Androgen

play40:40

and sensitivity this will impact where

play40:42

on this differential you actually land

play40:45

because it could be if it's complete

play40:47

insensitivity you may be like far on the

play40:50

end of you know you don't have some of

play40:53

these same uh advantages from an oxygen

play40:55

carrying capacity standpoint via

play40:57

multiple variables not just lung volume

play41:00

which we'll get into in a sec but in

play41:02

general females are going to have lower

play41:04

oxygen update capacity which is expected

play41:07

females also have about 85% the heart

play41:11

size of that of males and the volume of

play41:14

blood that you can actually pump around

play41:15

the body as a result of that obviously

play41:17

less heart size of males translates to a

play41:19

larger stroke volume as well and V2 Max

play41:23

as a result it's going to be 15 to 30%

play41:25

higher in Elite males than in females

play41:27

based on just straight up uh sex

play41:30

differential in terms of the anatomy

play41:32

functional capacity of the lungs as well

play41:35

varies based on even uh propensity to

play41:38

asthma so Androgen exposure seems to

play41:42

lower the incidence of asthma so the

play41:45

more female you are the more likely you

play41:47

are to have asthma seemingly and if you

play41:51

have mild in sensitivity versus partial

play41:53

versus complete this is obviously going

play41:54

to affect your the probability that you

play41:57

have severe asthma versus not among

play41:59

other factors that drive oxygen caring

play42:02

capacity as well like hematocrite you

play42:04

know affected individuals do not

play42:06

menstrate this is notable hugely notable

play42:10

in my opinion given that if you're

play42:11

competing in a sport that is highly

play42:13

dependent on your ability to have Elite

play42:15

endurance you know not having a period

play42:18

where you bleed out a bunch of your

play42:20

oxygen carrying capacity would be

play42:23

helpful you know you would not have to

play42:24

worry about that like a you know the

play42:26

average female would so just quick high

play42:28

level on red blood cell production worth

play42:31

noting hematocrit is the percentage of

play42:33

red cells in your blood and normal

play42:35

levels in men hematocrite probably it

play42:38

depends on the reference range in the

play42:39

lab but you know 40 to 54% it's typical

play42:42

for men whereas for women it's

play42:44

approximately 34 to 46% so obviously

play42:47

Less in women and androgens drive arthr

play42:50

poesis so the process of making red

play42:53

blood cells is significantly mediated by

play42:57

the ability of androgens to increase

play42:59

arthop potin concentrations so for

play43:01

somebody with complete Androgen and

play43:03

sensitivity it's entirely possible the

play43:05

net outcome of lack of menstration but

play43:07

concurrent lack of AR mediated arthr

play43:10

poesis might be you know net neutral net

play43:13

negative you know it's kind of hard to

play43:15

say compared to a menstruating female

play43:17

with full Androgen receptor activity but

play43:19

there's also obvious leeway given that

play43:21

this response at the Androgen receptor

play43:22

is all a spectrum as we mentioned

play43:24

different categories and individuals who

play43:26

are also a partial insensitivity you

play43:29

know based on some of the uh at least

play43:32

Olympic classifications not that they're

play43:34

being used now but even back then it was

play43:37

deemed to be a false positive if you had

play43:39

partial insensitivity or complete which

play43:41

is obviously going to be a differential

play43:42

between how much arthr poesis you can

play43:45

drive so there could easily be a net

play43:47

positive outcome if you only have

play43:49

partial AR and sensitivity and

play43:51

satisfactory or even male territory

play43:54

arthr poesis occurring in addition over

play43:56

the past few decades this is something

play43:58

that typically is not talked about

play44:00

evidence has begun to accumulate showing

play44:02

that the androgens in the body can have

play44:06

actions independent of the Androgen

play44:08

receptor and can still impart very

play44:11

significant rapid actions at the

play44:13

cellular and organism level without

play44:15

having to interact with the AR

play44:17

whatsoever this is known as the non-

play44:19

genomic pathway and it requires neither

play44:21

AR nuclear translocation nor AR DNA

play44:24

binding this is independent entirely

play44:27

from the Androgen receptor and even

play44:29

anti-androgens like bicalutamide that we

play44:31

talked about earlier and flutamide have

play44:34

no effect on non-genomic Androgen

play44:37

signaling as evidenced by studies

play44:40

evaluating if it is indeed the case or

play44:43

not that this is a AR or ar independent

play44:46

mediated thing and it turns out that

play44:48

there is in fact effects of androgens

play44:51

independent entirely if you were

play44:53

somebody who had complete insensitivity

play44:55

if you had natural testost levels that

play44:57

were that of a male there is some degree

play44:59

of effect that is happening outside of

play45:01

the receptor entirely and this is driven

play45:04

through metabolites into aromatization

play45:07

into estrogen and a bunch of different

play45:08

things but it seems to drive Androgen

play45:11

mediated functions despite not actually

play45:14

interacting with the Androgen receptor

play45:16

interestingly so one example is a

play45:18

notable case report from 2021 that

play45:21

details the case of a complete Androgen

play45:23

and sensitivity patient who underwent

play45:25

gonadectomy at Age 2 six so gonad ectomy

play45:29

is the actual surgical removal of their

play45:32

gonads and after they had that removal

play45:36

they actually had a decrease in libido

play45:39

like very significant decrease libido

play45:41

but they were able to reverse it by

play45:43

using testosterone very interesting

play45:45

because if this person had complete

play45:47

Androgen and sensitivity you would think

play45:49

okay well when you remove their goans

play45:51

there's going to be no difference in

play45:52

terms of how they feel how high their

play45:54

libido is ETC but the fact that it

play45:57

dropped dramatically and then increased

play46:00

back up with testosterone therapy

play46:02

indicates that there's something going

play46:04

on Independent of the AR so testosterone

play46:07

therapy led to a robust increase in

play46:09

sexual function which is inconsistent

play46:11

with a genomic action of testosterone

play46:13

and it is speculated you know this could

play46:15

be partly mediated by Central

play46:17

aromatization because estrogen does

play46:19

Drive some level of sexual function for

play46:21

sure if you've ever crushed your

play46:22

estrogen with aromatase Inhibitors or

play46:24

bodybuilders know just how bad it can be

play46:26

to have low estrogen but High test you

play46:28

can still have no libido but it is

play46:31

thought to also be mediated by

play46:33

non-genomic actions of androgens because

play46:35

exogenous estradi therapy in individuals

play46:38

with complete Androgen and Sensitivity

play46:40

Syndrome was not effective like

play46:42

testosterone was in reversing this so a

play46:44

recent randomized crossover trial with

play46:47

26 complete Androgen and Sensitivity

play46:49

Syndrome patients also found that

play46:51

exogenous testosterone did lead to an

play46:53

improvement in sexual function so there

play46:55

is little debate as as well when it

play46:57

comes to psychoactive effects that

play46:59

better motor skills visual spatial

play47:01

skills and pro perception will improve

play47:04

coordination and subsequent athletic

play47:05

performance the sex specific

play47:08

connectivity of sub networks in the

play47:10

brain are thought to underly the ability

play47:11

of males to show consistently higher

play47:14

levels of performance in these areas and

play47:15

you know when we see these non- genomic

play47:17

effects of androgens you can't help but

play47:19

think there seems to be some effect

play47:22

independent of AR that is traditionally

play47:24

like masculinizing through non genomic

play47:27

effects and then for somebody with

play47:28

partial activity or partial response you

play47:31

can assume they're going to have some of

play47:33

these like male characteristic effects

play47:35

that otherwise give them a uniquely male

play47:39

Spectrum level advantage over females

play47:41

and that's just over females without any

play47:44

predispositions like this which is just

play47:46

the reality so depending on the mutation

play47:48

a person with a 46xy carot type and

play47:51

androgen and Sensitivity Syndrome can

play47:53

have either a male or female phenotype

play47:57

or may have genitalia that are only

play47:58

partially masculinized and ultimately

play48:01

this insensitivity syndrome is the

play48:03

largest single entity that leads to

play48:05

46xy under masculinized genitalia so

play48:09

even with unethical level scrutiny if

play48:11

you want to call it that someone with

play48:13

partial Androgen and Sensitivity

play48:15

Syndrome could still pass like the most

play48:17

crude sex verification test if they are

play48:20

exempting all individuals that are XY

play48:23

with partial Androgen and Sensitivity

play48:25

Syndrome and complete they could compete

play48:26

against women and potentially depending

play48:28

on the condition and severity have a net

play48:30

Advantage via higher testosterone levels

play48:33

some level of direct genomic effects if

play48:35

they have partial insensitivity the full

play48:37

capacity of the non- genomic effects of

play48:39

androgens which are becoming more well

play48:41

understood as the years pass and more

play48:42

literature emerges longer limbs bigger

play48:44

hands being taller more muscle mass

play48:47

depending on the severity bigger lungs

play48:49

potentially bigger heart less prone to

play48:51

asthma more of arthop poesis not

play48:54

menstruating there are a lot of factors

play48:56

here so in the Caster Sania case

play48:58

revisiting this for a final time the

play49:01

extreme example of somebody who's a Gold

play49:03

Medal winner but has fully functional

play49:06

internal testes producing male level

play49:08

testosterone functional Androgen

play49:10

receptors having undergone full

play49:12

development or at least the development

play49:14

to which the testosterone levels allow

play49:16

masculinization wise but on the muscle

play49:19

tissue bone mass Etc side like that is

play49:21

full capacity of those natural

play49:23

testosterone levels without inhibition

play49:25

via anti Ander cuz this wasn't a

play49:28

mandatory requirement when Caster was

play49:30

competing until she decided not to

play49:32

compete anymore cuz she would not abide

play49:34

by those rules but she was able to still

play49:36

win when that was not a requirement like

play49:38

it's hard to argue that that individual

play49:41

with that specific set of circumstances

play49:43

does not have a significant unfair

play49:45

Advantage you know you could argue the

play49:47

whole you know individuals who have

play49:49

unique genetic predispositions like

play49:51

Michael Phelps or whatever that result

play49:52

in unique performance advantages over

play49:56

competitors You could argue that well

play49:58

this is just that again but then it it

play50:00

calls into question what is the validity

play50:03

or actual like point of even even having

play50:07

segregated gender categories at all like

play50:09

we have Men Sport and women sport like

play50:11

does it even make sense at this point

play50:13

when you are just claiming that an

play50:15

individual who is has internal testies

play50:18

that produces male level testosterone

play50:20

levels and fully response to those

play50:21

testosterone levels is a superior female

play50:24

like that's basically what you're

play50:25

claiming from performance standpoint if

play50:27

you wanted to shoehorn that person into

play50:31

a you know female division that's not to

play50:33

say that it's fair for that person but

play50:36

it's certainly not fair for women who

play50:38

have to deal with normal female

play50:40

physiology to compete against somebody

play50:42

who has literal male development like

play50:45

that is not fair so I would say in the

play50:47

case of the five Alpha reductase

play50:49

deficiency depending on the person

play50:50

depending on the functional capacity of

play50:52

the testes Etc like that is a situation

play50:55

where that person should have been

play50:56

probably identified and subject to

play50:59

either I don't necessarily think that

play51:01

the whole anti-androgen situation the

play51:03

threshold C offs I don't necessarily

play51:05

think that's a perfect system but at the

play51:07

end of the day Caster should not in my

play51:09

opinion somebody with that level of

play51:12

unique uh predisposition should not be

play51:16

put in the exact same playing field as

play51:18

somebody who literally does not have

play51:20

these same organs to work with you know

play51:24

like it's different when you talk about

play51:26

males to have specific Anatomy for males

play51:30

that give them an advantage like Michael

play51:31

Phelps or mutations and genes that

play51:34

encode for some process that is

play51:36

significantly more efficient than

play51:37

another male but at the end of the day

play51:39

like this is the criteria we're dealt

play51:41

with is segregating Sport by gender once

play51:44

you start to shoehorn individuals with

play51:47

male territory performance via their

play51:51

male predisposed development that they

play51:54

actually were supposed to go down should

play51:57

they not have had a mutation in the gene

play51:58

that encodes for five Alpha reduct a

play52:00

like you've essentially defeated the

play52:03

Integrity of these gender categories

play52:05

entirely to which it's like what's the

play52:06

[ __ ] point you might as well have

play52:07

everyone compete against everyone at

play52:09

this point which is obviously dumb but I

play52:10

mean I don't think that that case makes

play52:12

sense to have somebody with that unique

play52:14

of an advantage competing against just

play52:16

straight up women without internal

play52:18

testies however what is the takeaway for

play52:21

this situation with Yan khif and Lynn so

play52:24

I think chromosomes matter I think think

play52:26

the genes matter I think the hormone

play52:28

levels matter and I think the DSD

play52:30

category plus medical condition of these

play52:33

Fighters matters I think a lot of this

play52:35

information we just went over is of

play52:37

critical importance to carefully

play52:38

evaluate in a nuanced manner among each

play52:41

fighter and it was essentially just

play52:43

thrown out the window in Olympic boxing

play52:45

seemingly as there was not only no sex

play52:47

verification testing but there was also

play52:49

no testosterone threshold C offs or

play52:51

regulated limits in the Olympics nor

play52:53

were there you know mandatory

play52:55

anti-androgen requirements or anything

play52:57

of that nature I am not to say that

play52:59

that's a perfect system but at the end

play53:00

of the day like there was nothing in

play53:01

place to prevent somebody from competing

play53:04

who has you know even greater

play53:07

predispositions than you know Caster

play53:10

seemingly so despite you know neither of

play53:13

those tests are perfect and there's a

play53:14

ton of room to maneuver and cheat that

play53:16

system but there's a reason why other

play53:17

sports at least have cut offs in place

play53:20

to do something to try and somewhat

play53:23

allow parody here and to be inclusive so

play53:26

despite other sports in the Olympics

play53:28

this year having rigorous C offs there

play53:30

is no formal oversight body for boxing

play53:33

supposedly the ioc created an ad hoc

play53:35

boxing unit to temporarily oversee the

play53:38

boxing competition in Paris and this

play53:40

unit has no guidelines for gender

play53:42

eligibility seemingly or the extent to

play53:45

which it is is basically allowing boxers

play53:47

to compete as females if they have

play53:49

female gender markers on their passports

play53:52

or legal documents so if you had a

play53:54

passport that showed you were a female

play53:56

you were eligible to fight in the

play53:57

women's category that is what we've been

play53:59

led to believe so to determine if Iman

play54:02

khif or Lin yuting have a semblance of a

play54:05

male level Advantage they need to be

play54:06

tested and until the ioc makes clear

play54:09

what their specific criteria is for

play54:11

eligibility above and beyond what's on

play54:12

your passport and how they're ensuring

play54:14

fairness in situations like this that

play54:16

can be you know debated at that point as

play54:19

to if that criteria is sufficient or not

play54:22

we can only assume you know without any

play54:24

more information that there is a

play54:27

possibility that under viralized men are

play54:30

winning gold medals in women's sports at

play54:32

an Olympic level and also punching women

play54:34

in the head in the ring like that's with

play54:36

the lack of information given we can

play54:38

assume that that is certainly a

play54:41

possibility and it's wild that this is

play54:44

occurring in 2024 it's very unfortunate

play54:47

that these two individuals that again

play54:50

not born as biologic men going through

play54:53

full puberty and then transitioning to

play54:55

women and then trying to compete in

play54:57

boxing or something these individuals

play54:59

are born as women and believe

play55:01

wholeheartedly that they are just

play55:03

natural normal healthy young women and

play55:08

all of a sudden are thrust under

play55:09

scrutiny like this and basically getting

play55:12

[ __ ] on by the public for having

play55:14

competed against women it's a highly

play55:17

contentious and weird

play55:20

situation and I also do uh empathize

play55:24

with those individuals who really

play55:27

probably have no clear-cut understanding

play55:29

of what's going on like this is

play55:31

seemingly a very recent thing they were

play55:32

disqualified and who knows if they know

play55:34

what that means or why they were

play55:36

disqualified and if it made sense cuz if

play55:38

you were disqualified last year for

play55:40

something in your test and then in 2024

play55:43

you were eligible it's like okay well

play55:44

you would think at the highest level of

play55:46

sport in the Olympics whatever their

play55:48

tests are would be the criteria of which

play55:51

is okay I'm obviously good to go nor

play55:54

would you even think like hopefully I

play55:55

can fin this test cuz you just think

play55:57

you're a woman this entire time which

play55:59

you know you could be unless you're told

play56:01

otherwise via proof and you have some

play56:03

sort of clear-cut test eligibility

play56:05

requirements that would dictate that you

play56:07

are or aren't you can't have somebody

play56:09

getting away with having a 5 AR

play56:11

deficiency with male level test levels

play56:13

and punching women in the head so

play56:14

hopefully that's not the case and

play56:15

hopefully they have I guess the spectrum

play56:19

of Androgen and sensitivity that would

play56:21

otherwise net out to female territory

play56:24

performance levels but we have no idea

play56:26

if that the case and we will not know

play56:28

unless more information is presented

play56:30

that may be otherwise too much of a

play56:32

privacy concern to be releasing to the

play56:34

public at which point it's like okay

play56:37

well I don't know does it just suck for

play56:39

you then if you're an individual born

play56:41

like this maybe unfortunately but I also

play56:44

think that for fairness of women's sport

play56:46

you almost have to have that level of

play56:48

scrutiny all but maybe not publicized to

play56:51

the public but there should be clear-cut

play56:53

criteria that somebody needs to meet

play56:55

that the public knows what the criteria

play56:57

is and then the athletes are tested

play56:58

accordingly to determine that they don't

play57:01

have response to male level Androgen

play57:05

levels that is reflective of that of a

play57:08

male I think that's a fairly General and

play57:10

logical statement I'm got a my brain is

play57:13

absolutely [ __ ] warped at this point

play57:15

but hopefully you guys uh learned

play57:17

something from that found it interesting

play57:18

wild controversial situation and without

play57:22

the actual specific categorical

play57:26

identification and medical condition and

play57:30

Analysis of hormone levels and

play57:32

chromosomes and genes we have no idea at

play57:34

the end of the day if this is fair or

play57:36

not so to be determined maybe but

play57:39

hopefully these individuals are

play57:42

otherwise you know equated to what is

play57:46

just a you know normal functioning woman

play57:48

at the end of the day when it comes to

play57:49

the capacity for you know muscle

play57:51

building blood building bone mass Etc

play57:55

but it's hard to Overlook some of these

play57:57

anatomical differences and even slight

play58:00

sensitivity at the receptor and these

play58:02

non- genomic effects and the fact that

play58:05

individuals likely if they have internal

play58:07

testes have male level hormone levels

play58:10

it's like really hard to overlook that

play58:12

there should be higher scrutiny on this

play58:13

than a [ __ ] passport so anyways let

play58:16

me know what you guys think in the

play58:17

comments down below all the comments

play58:18

help the algorithm Are Much appreciated

play58:20

like subscribe check out my blog more

play58:21

plates more dates.com uh I'm laughing

play58:24

cuz I'm saying my outro as if it's still

play58:28

like a relevant outro like I don't even

play58:30

write on my site anymore so I don't know

play58:32

maybe you shouldn't go to more pls.com

play58:34

it just exists at this point but

play58:35

subscribe to here because I actually

play58:37

post stuff here and follow me on social

play58:39

media other platforms Instagram Etc if

play58:41

you want to support me anything in the

play58:43

video description below gorilla mind

play58:46

pre-workout new Tropic formulas

play58:49

Innovative energy drinks even now from a

play58:52

new Tropic formulation standpoint if you

play58:54

haven't seen those you're missing out

play58:56

[ __ ] incredible most efficacious

play58:58

energy drink mer health for preventative

play59:00

medicine highle Diagnostics hormone

play59:02

replacement therapy Etc also intelligent

play59:06

shop for hair loss prevention uh men's

play59:09

fragrance skin care and anything else

play59:12

I'm associated with it's all in the

play59:13

video description below thank you guys

play59:15

for watching talk to you soon

Rate This

5.0 / 5 (0 votes)

الوسوم ذات الصلة
Gender VerificationOlympic BoxingPerformance AdvantageBiological MaleAndrogen SensitivitySports EquityChromosomal AnalysisTestosterone LevelsIOC RegulationsAthletic Fairness
هل تحتاج إلى تلخيص باللغة الإنجليزية؟